Drugs / MECLOFENOXATE
last change Feb 2020 re-read 2 minutes ago

MECLOFENOXATE

Small molecule

Developed for
hepatic encephalopathy

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT03961087 Comparator May 2019 → Jan 2020 hepatic encephalopathy, intellectual disability Zagazig University Unknown No outcome recorded

Evidence & citations 10 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as MECLOFENOXATE ClinicalTrials.gov intervention name — accepted as the source's own label NCT03961087
Known as Analux ChEMBL registry synonym — accepted as the source's own label CHEMBL64545
Known as ANP-235 ChEMBL registry synonym — accepted as the source's own label CHEMBL64545
Known as CENTROPHENOXINE HYDROCHLORIDE ChEMBL registry synonym — accepted as the source's own label CHEMBL64545
Known as Cetrexin ChEMBL registry synonym — accepted as the source's own label CHEMBL64545
Known as Meclofenoxane ChEMBL registry synonym — accepted as the source's own label CHEMBL64545
Known as Meclofenoxato ChEMBL registry synonym — accepted as the source's own label CHEMBL64545
Known as NSC-169411 ChEMBL registry synonym — accepted as the source's own label CHEMBL64545
Known as Proseryl ChEMBL registry synonym — accepted as the source's own label CHEMBL64545
Modality Small molecule CHEMBL64545